Cite
HARVARD Citation
Ayabe, K. et al. (2013). AB0318 Abatacept (abt) equivalent to anti-tumor necrosis factor a (tnfa) in terms of joint destruction inhibition: multicenter study of 107 patients treated for 52 weeks. Annals of the rheumatic diseases. p. A884. [Online].